Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
116 studies found for:    "Lipodystrophy"
Show Display Options
Rank Status Study
1 Active, not recruiting Trial of Leptin Replacement Therapy in Patients With Lipodystrophy
Conditions: Hypoleptinemia;   Generalized Lipodystrophy;   Partial Lipodystrophy;   Insulin Resistance
Interventions: Drug: Leptin;   Drug: Placebo
2 Recruiting Therapeutic Approaches to HAART-Induced Lipodystrophy
Conditions: HIV Infections;   Lipodystrophy
Intervention: Drug: Metreleptin  (Leptin)
3 Enrolling by invitation Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
Conditions: Lipodystrophy;   Diabetes;   Hyperlipidemia
Intervention: Drug: Metreleptin
4 Active, not recruiting Leptin to Treat Lipodystrophy
Condition: Lipodystrophy
Intervention: Drug: Metreleptin
5 Completed Corticosteroid-induced Lipodystrophy and Adipokines
Condition: Lipodystrophy
Intervention: Other: Samples and procedures
6 Recruiting Identification of a New Gene Involved in Hereditary Lipodystrophy
Condition: Lipodystrophy
Interventions: Genetic: Amplification by PCR and direct sequencing on the entire coding sequence and intron-exons boundaries of the candidate gene;   Biological: Perform blood cells and fibroblasts biochemical and immuno-labeled investigations
7 Recruiting Short-term Effects of Leptin in People With Lipodystrophy
Condition: Lipodystrophy
Intervention: Biological: Metreleptin
8 Unknown  Autologous Adipose-Derived Stem Cell Transplantation in Patients With Lipodystrophy
Condition: Lipodystrophy
Intervention: Procedure: autologous transplantation of liposuction material enriched with adipose-derived stem cells
9 Enrolling by invitation Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy
Conditions: Diabetes;   Lipodystrophy;   Hyperlipidemia
Intervention: Drug: Metreleptin
10 Active, not recruiting An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy
Condition: Lipodystrophy
Intervention: Drug: metreleptin
11 Completed Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy
Condition: HIV-Associated Lipodystrophy Syndrome
Interventions: Drug: Standard continuous antiretroviral therapy;   Drug: CD-4 guided therapy interruption;   Drug: Viral load driven treatment interruption
12 Recruiting Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy
Conditions: Fatty Liver Disease, Nonalcoholic;   Nonalcoholic Steatohepatitis;   Lipodystrophy
Intervention: Drug: Metreleptin
13 Terminated Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy
Conditions: HIV-Associated Lipodystrophy;   HIV Infections
Intervention: Device: poly-L-lactic acid
14 Withdrawn Clinical Trial to Determine the Efficacy of Sculptra™ Dermal Filler for the Correction of Contour Deformities Caused by Lipoatrophy
Conditions: Lipodystrophy;   Emaciation
Intervention: Device: Sculptra Injection
15 Terminated Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy
Conditions: HIV Infections;   HIV Lipodystrophy Syndrome
Interventions: Drug: non-nucleoside reverse transcriptase inhibitors;   Drug: nucleoside reverse transcriptase inhibitors;   Drug: protease inhibitors
16 Unknown  Randomized, Placebo-Controlled Study of Leptin for the Treatment of HIV Lipodystrophy and Metabolic Syndrome
Condition: HAART-induced Lipodystrophy and Metabolic Syndrome
Intervention: Drug: r-metHuLeptin
17 Terminated Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients
Conditions: HIV Infections;   HIV-Associated Lipodystrophy Syndrome
Interventions: Drug: non-nucleoside reverse transcriptase inhibitors;   Drug: nucleoside reverse transcriptase inhibitors;   Drug: protease inhibitor
18 Terminated Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients
Conditions: HIV-Associated Lipodystrophy Syndrome;   HIV Infections
Intervention: Drug: Pioglitazone
19 Completed Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE
Condition: HIV-Associated Lipodystrophy Syndrome
Interventions: Device: Newfill;   Device: Eutrophill
20 Completed Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome
Condition: HIV Lipodystrophy
Interventions: Drug: Human recombinant leptin ("metreleptin");   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years